This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Here, Francine de Stoppelaar shares her top tips for implementing effective closed loop medicines management systems as part of a hospitals digital transformation journey to enhance patientcare, reduce expenditures and build a sustainable future for healthcare. Right patient 2. Right documentation. Right medication 3.
The ESC Congress 2024 spotlight was ‘Personalising Cardiovascular Care’, with the main aim of promoting tailored patientcare and moving away from the one-size-fits-all approach to treatment. In light of HELIOS-B trial results , as Professor Esther Gonzalez Lopez commented, for patients with amyloidosis the future is brighter.
In 2019, more than 148 million doses of medicine were lost , endangering both patients and employees. million doses were diverted in 2018, equal to the population of Arizona and California combined. It allows nurses more time to focus on direct patientcare and saves both nursing and pharmacy time from resolving discrepancies.
The CAR T-cell therapy tisagenlecleucel has recently been given the green light for routine rollout on the NHS to treat paediatric patients with acute lymphoblastic leukaemia. How do you envision the routine NHS rollout of tisagenlecleucel improving patientcare and outcomes?
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content